RDA Financial Network Raises Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

RDA Financial Network raised its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 3.4% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 9,282 shares of the healthcare conglomerate’s stock after buying an additional 304 shares during the period. UnitedHealth Group accounts for about 1.4% of RDA Financial Network’s investment portfolio, making the stock its 13th biggest holding. RDA Financial Network’s holdings in UnitedHealth Group were worth $4,861,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Geode Capital Management LLC grew its stake in shares of UnitedHealth Group by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 19,956,219 shares of the healthcare conglomerate’s stock worth $10,068,869,000 after acquiring an additional 319,515 shares during the last quarter. Capital International Investors increased its stake in UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate’s stock valued at $7,899,905,000 after purchasing an additional 906,365 shares in the last quarter. Norges Bank acquired a new stake in shares of UnitedHealth Group during the fourth quarter worth $6,375,744,000. Northern Trust Corp increased its position in shares of UnitedHealth Group by 12.5% in the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock valued at $4,807,527,000 after acquiring an additional 1,058,488 shares during the period. Finally, Franklin Resources Inc. lifted its position in UnitedHealth Group by 10.7% during the 4th quarter. Franklin Resources Inc. now owns 8,923,770 shares of the healthcare conglomerate’s stock worth $4,514,178,000 after acquiring an additional 861,854 shares during the period. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the business’s stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, with a total value of $25,019,019.00. Following the completion of the transaction, the chief executive officer now directly owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy Patrick Flynn acquired 1,533 shares of the company’s stock in a transaction dated Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now directly owns 6,033 shares of the company’s stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their position. The disclosure for this purchase can be found here. Insiders acquired 109,408 shares of company stock worth $31,607,768 over the last three months. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $303.24 on Friday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market cap of $275.08 billion, a PE ratio of 19.56, a PEG ratio of 1.37 and a beta of 0.44. UnitedHealth Group Incorporated has a one year low of $248.88 and a one year high of $630.73. The firm has a fifty day moving average of $409.03 and a 200 day moving average of $483.40.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same period in the prior year, the business posted $6.91 earnings per share. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.92%. The ex-dividend date of this dividend is Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s payout ratio is 37.02%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on UNH shares. Argus cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Monday, April 21st. TD Securities restated a “hold” rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. JPMorgan Chase & Co. decreased their target price on shares of UnitedHealth Group from $525.00 to $405.00 and set an “overweight” rating for the company in a research report on Thursday, May 15th. Barclays reduced their price objective on UnitedHealth Group to $350.00 and set an “overweight” rating for the company in a research note on Monday, June 2nd. Finally, Robert W. Baird dropped their target price on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating on the stock in a report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have given a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $428.43.

View Our Latest Report on UnitedHealth Group

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.